Clinical Trial Update: Bergamot and Cardio-Metabolic Risk Factors

View source ↗

Summary

A completed clinical trial from the University of Palermo evaluated bergamot extract for effects on dyslipidemia and cardio-metabolic risk factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Bergamot extract (bergamot extract)

Snippet

Sponsor: University of Palermo | Conditions: Dyslipidemia | Status: COMPLETED